< Go Back To Publications

Natalizumab Blocks Adhesion of Sickle Cell Whole Blood Cells to Activated Endothelial Cells under Flow Conditions.

Natalizumab Blocks Adhesion of Sickle Cell Whole Blood Cells to Activated Endothelial Cells under Flow Conditions.

Abstract, Sickle Cell Disease

September 26, 2014
0% read
Subscribe to our Newsletter

Wayne State University School of Medicine

White JC:
Subscribe to our Newsletter
Subscribe to our Newsletter

Recommended Reads

Jan 31, 2024

Functional Fluidics Founder & CEO, Patrick Hines, to be honored at the Detroit Historical Society Hustle Gala

Dec 19, 2023

Functional Fluidics Poster Presentation at the 65th ASH Annual Meeting & Exposition

Contact Us
 

Our Location

440 Burroughs Street,
Suite 641
Detroit, MI
48202
United States

Email: info@functionalfluidics.com
Phone:313-315-2555

Subscribe to Our Newsletter

© Copyright Functional Fluidics 2016.